| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1836 | 2019 |
| Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ... EMBO molecular medicine 4 (5), 380-395, 2012 | 642 | 2012 |
| Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease Y Compta, MJ Martí, N Ibarretxe‐Bilbao, C Junqué, F Valldeoriola, ... Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009 | 217 | 2009 |
| G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies C Gaig, MJ Martí, M Ezquerra, MJ Rey, A Cardozo, E Tolosa Journal of Neurology, Neurosurgery & Psychiatry 78 (6), 626-628, 2007 | 165 | 2007 |
| Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease T Botta‐Orfila, X Morató, Y Compta, JJ Lozano, N Falgas, F Valldeoriola, ... Journal of neuroscience research 92 (8), 1071-1077, 2014 | 164 | 2014 |
| Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ... Molecular neurobiology 54, 5550-5562, 2017 | 158 | 2017 |
| Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ... EMBO molecular medicine 7 (12), 1529-1546, 2015 | 149 | 2015 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 145 | 2021 |
| Significant association between the tau gene A0/A0 genotype and Parkinson's disease P Pastor, M Ezquerra, E Muñoz, MJ Martí, R Blesa, E Tolosa, R Oliva Annals of Neurology: Official Journal of the American Neurological …, 2000 | 144 | 2000 |
| LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance C Gaig, M Ezquerra, MJ Marti, E Munoz, F Valldeoriola, E Tolosa Archives of neurology 63 (3), 377-382, 2006 | 136 | 2006 |
| Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain A Lleó, R Blesa, R Queralt, M Ezquerra, JL Molinuevo, J Pena-Casanova, ... Archives of neurology 59 (11), 1759-1763, 2002 | 126 | 2002 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 112 | 2019 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 93 | 2019 |
| Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease C Gaig, D Vilas, J Infante, M Sierra, I Garcia-Gorostiaga, M Buongiorno, ... PloS one 9 (10), e108982, 2014 | 92 | 2014 |
| Further extension of the H1 haplotype associated with progressive supranuclear palsy P Pastor, M Ezquerra, E Tolosa, E Muñoz, M José Martí, F Valldeoriola, ... Movement disorders: official journal of the Movement Disorder Society 17 (3 …, 2002 | 85 | 2002 |
| The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ... Movement Disorders 34 (4), 460-468, 2019 | 84 | 2019 |
| A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures M Ezquerra, C Carnero, R Blesa, JL Gelpi, F Ballesta, R Oliva Neurology 52 (3), 566-566, 1999 | 84 | 1999 |
| Rapidly progressive diffuse Lewy body disease C Gaig, F Valldeoriola, E Gelpi, M Ezquerra, S Llufriu, M Buongiorno, ... Movement disorders 26 (7), 1316-1323, 2011 | 81 | 2011 |
| Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies I Ferrer, I Hernandez, M Boada, A Llorente, MJ Rey, A Cardozo, ... Acta neuropathologica 106, 419-435, 2003 | 81 | 2003 |
| Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection R Oliva, E Tolosa, M Ezquerra, JL Molinuevo, F Valldeoriola, J Burguera, ... Archives of neurology 55 (8), 1122-1124, 1998 | 81 | 1998 |